St. Luke’s Hospital has been designated as a Pulmonary Fibrosis Foundation Care Center Network site, bringing high quality care close to home for patients with fatal lung disease.
“Being named a PFF Care Center Network site indicates that St. Luke’s Hospital has the experience and expertise to diagnose and treat patients with a variety of complex, fibrotic lung diseases,” said Neil Ettinger, MD, St. Luke’s Hospital Chief of Pulmonology. “This designation reflects our commitment to integrating research and high quality care to improve the lives of our patients.”
In addition to receiving expert diagnosis and treatment, patients will benefit from St. Luke’s participation in the network by receiving recommendations for continuing care, including lung transplantation, and assistance in locating necessary social services. Eligible patients will also have the opportunity to take part in clinical trials. St. Luke’s Hospital offers a quarterly support group meeting for patients who have idiopathic pulmonary fibrosis.
More than 200,000 Americans are living with IPF, a complex disease which causes progressive scarring in the lungs. Nationwide, IPF causes more than 40,000 deaths annually, and 50,000 new cases are diagnosed each year. There is no known cure.
“As the leading resource for the pulmonary fibrosis community, the Pulmonary Fibrosis Foundation is dedicated to developing new tools and support to help ensure patients receive a swift and accurate diagnosis along with the highest quality of care,” said Dr. Gregory P. Cosgrove, PFF chief medical officer. “The launch of our 15 new Care Center Network sites provides crucial resources for care along with an infrastructure that facilitates research toward a cure.”
The PFF Care Center Network now includes 60 sites in 30 states.